Trial intelligence / Profile preview

Testosterone gel versus placebo in men with abdominal obesity, low testosterone, and early metabolic syndrome

2006-003101-53Phase 4Completed

Sponsor
Karolinska Institutet
Start
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in cardiometabolic risk (CMR) and Hypoandrogenism (TD) comparing Testosterone gel with Placebo (2 arms). Primary endpoint: Insulin sensitivity by QUICKI. Started Nov 2006; status: completed.

02

Drugs

testosterone
03

Conditions

cardiometabolic risk (CMR)Hypoandrogenism (TD)

Beyond the preview

Go deeper on 2006-003101-53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003101-53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call